| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/25/2012 | EP2443155A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides |
| 04/25/2012 | EP2443144A1 Sap variants and their use |
| 04/25/2012 | EP2443143A1 Casein derived protease inhibitory peptides |
| 04/25/2012 | EP2443136A1 Novel peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation |
| 04/25/2012 | EP2442832A1 Compositions and methods for treatment of multiple sclerosis |
| 04/25/2012 | EP2442824A2 Protease variants |
| 04/25/2012 | EP2442823A1 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same |
| 04/25/2012 | EP2442822A2 Peptide therapy for increasing platelet levels |
| 04/25/2012 | EP2442821A1 Safe desmopressin administration |
| 04/25/2012 | EP2442820A1 Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders |
| 04/25/2012 | EP2442805A1 Nanodispersion of a drug and process for its preparation |
| 04/25/2012 | EP2442800A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 04/25/2012 | EP2442651A1 Treatment of multiple sclerosis with laquinimod |
| 04/25/2012 | EP2428216A9 Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 04/25/2012 | EP2288375B1 Pegylated insulin lispro compounds |
| 04/25/2012 | EP2265631B1 Novel antimicrobial peptides and their application |
| 04/25/2012 | EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions |
| 04/25/2012 | EP2068909B1 Modified fgf-21 polypeptides and their uses |
| 04/25/2012 | EP2013200B1 Polyamides for treating human papilloma virus |
| 04/25/2012 | EP1996715B1 Bacterial antigens and uses thereof |
| 04/25/2012 | EP1968538B1 Pharmaceutical compositions comprising cyclosporin |
| 04/25/2012 | EP1966238B1 Interleukin-12p40 variants with improved stability |
| 04/25/2012 | EP1753448B1 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 04/25/2012 | EP1706150B1 Stable growth hormone liquid formulation |
| 04/25/2012 | EP1575477B1 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR |
| 04/25/2012 | EP1383490B1 Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases |
| 04/25/2012 | EP1381432B9 HSA-free formulations of interferon-beta |
| 04/25/2012 | EP1379551B1 Adp-ribosylating bacterial toxins |
| 04/25/2012 | EP1356277B1 Method for altering cell fate |
| 04/25/2012 | EP1112084B2 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 04/25/2012 | EP0773997B2 Htk ligand |
| 04/25/2012 | CN1953762B Gst活化的抗癌化合物在制备改善铂类化合物的抗癌副作用的药物中的用途 Gst-activated anticancer compound in the preparation of the platinum compounds to improve the side effect of anticancer drugs in use |
| 04/25/2012 | CN1921878B 属于Bcl-2家族的蛋白和其片段,和它们在癌症患者中的用途 Belonging to the Bcl-2 family of proteins and their fragments, and their use in cancer patients |
| 04/25/2012 | CN1805758B Nucleotide and cellular vaccine composition |
| 04/25/2012 | CN1756558B Specific chaperone combination for enzyme and active parts of the enzyme |
| 04/25/2012 | CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 04/25/2012 | CN102428371A Peptide ligands of somatostatin receptors |
| 04/25/2012 | CN102428175A Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 04/25/2012 | CN102428098A Novel solid materials of {[2s, 5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them |
| 04/25/2012 | CN102428096A Cell membrane-permeable peptides |
| 04/25/2012 | CN102428095A 新型蛋白酶体激活性抗衰老肽及含有所述肽的组合物 Novel protease-activating anti-aging peptides and compositions containing the peptides |
| 04/25/2012 | CN102428094A Collagen peptide composition having good blood transfer properties, and food and drink containing same |
| 04/25/2012 | CN102428081A 艾波度坦(men15596)和相关中间体的制备方法 Preparation Appleby degrees Tanzania (men15596) and related intermediates |
| 04/25/2012 | CN102428075A Crystalline tripeptide epoxy ketone protease inhibitors |
| 04/25/2012 | CN102427825A Fertilization modulation compounds and process for implementing them |
| 04/25/2012 | CN102424698A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/25/2012 | CN102424680A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 04/25/2012 | CN102423487A 一种骨关节保健组合物及其应用 A bone joint health composition and its application |
| 04/25/2012 | CN102423486A 肽康灵食品配药配方 Peptide Kang Ling food dispensing recipe |
| 04/25/2012 | CN102423485A 含有醋酸去氨加压素的口服组合物及其制备方法 Desmopressin acetate oral composition and preparation method comprising |
| 04/25/2012 | CN102423484A 一种稳定的西曲瑞克药物组合物及其制备方法 Cetrorelix a stable pharmaceutical composition and its preparation method |
| 04/25/2012 | CN102423483A 一种复方雷米普利纳米乳抗高血压药物 A COMPOUND ramipril nanoemulsion antihypertensives |
| 04/25/2012 | CN102423482A 复方氨氯地平赖诺普利片的制备方法 Preparation of compound amlodipine lisinopril tablets |
| 04/25/2012 | CN102423298A Preparation method of core-shell structure collagen polypeptide chelated calcium nanoparticle |
| 04/25/2012 | CN101974076B 抑制由碱性成纤维细胞生长因子诱导的细胞增殖及血管增生的环肽 Inhibition by basic fibroblast growth factor-induced cell proliferation and angiogenesis cyclic peptide |
| 04/25/2012 | CN101940795B DLK1基因的用途以及siRNA、BM-MSCs和FGF2 DLK1 gene use and siRNA, BM-MSCs and FGF2 |
| 04/25/2012 | CN101940784B 一种药膏及其制备方法 An ointment and its preparation method |
| 04/25/2012 | CN101780031B 一种用于修复皮肤创面或宫颈粘膜的诱导凝胶 A method for repairing skin wounds or cervical mucosa induced gelation |
| 04/25/2012 | CN101731178B 养殖环境调节剂、制备方法及其在畜禽养殖业中的应用 Breeding environment regulators, preparation method and its application in the livestock industry |
| 04/25/2012 | CN101607984B 一种多拷贝多肽及其应用 A multi-copy peptide and its application |
| 04/25/2012 | CN101554475B 次血红素短肽化合物在抗脑缺血药物制备中的用途 Times heme peptide compounds in the manufacture of anti-cerebral ischemia drug use |
| 04/25/2012 | CN101503457B 柱层析peg与干扰素类似物蛋白氮端定点偶联方法及其产物 Column chromatography peg interferon analog protein nitrogen end point coupling methods and their products |
| 04/25/2012 | CN101445548B 一种中药何首乌蛋白质的提取方法及其应用 A protein extraction method and its application of traditional Chinese medicine Polygonum multiflorum |
| 04/25/2012 | CN101434649B 一种环七肽及其制备方法和应用 A cyclic heptapeptide and its preparation method and application |
| 04/25/2012 | CN101392252B 一种细尖狼蝎Kv1.3阻断剂基因及制备方法和应用 A fine tip wolf Kv1.3 blockers scorpion gene and preparation method and application |
| 04/25/2012 | CN101376676B 聚乙二醇化红细胞生成素蛋白长效制剂 PEGylated erythropoietin protein drug depot |
| 04/25/2012 | CN101361717B 巴曲酶冻干粉针制剂及其制备方法 Batroxobin freeze-dried powder and its preparation method |
| 04/25/2012 | CN101353663B 一种抗i型糖尿病融合蛋白及其制备方法 An anti-i fusion protein of Diabetes and its preparation method |
| 04/25/2012 | CN101163712B Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation |
| 04/25/2012 | CN101111256B 抗菌肽及其使用方法 Antimicrobial peptides and methods of use |
| 04/24/2012 | US8165819 Modeling wound healing |
| 04/24/2012 | US8163921 Hepatitis C virus inhibitors |
| 04/24/2012 | US8163890 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 04/24/2012 | US8163879 Fusion molecules and IL-15 variants |
| 04/24/2012 | US8163875 Polymer conjugated glycosylated neublastin |
| 04/24/2012 | US8163873 Isolated microtubule-associated protein tau peptides and kit |
| 04/24/2012 | US8163734 Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses |
| 04/24/2012 | US8163717 Dual chain synthetic heparin-binding growth factor analogs |
| 04/24/2012 | US8163712 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/24/2012 | US8163710 Reduction of graft-versus-host disease by modulation of SHIP activity |
| 04/24/2012 | US8163702 Treatment of melanoma |
| 04/24/2012 | US8163701 Prodrugs of active agents |
| 04/24/2012 | US8163700 Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration |
| 04/24/2012 | US8163699 Method for the treatment of valvular disease |
| 04/24/2012 | US8163698 Dolastatin 15 derivatives |
| 04/24/2012 | US8163697 Selective R-cadherin antagonists and methods |
| 04/24/2012 | US8163696 Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues |
| 04/24/2012 | US8163695 Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 04/24/2012 | US8163694 Method of treating diseases or abnormal conditions of periodontal or dental tissues with GDF5 |
| 04/24/2012 | US8163693 Urea-containing peptides as inhibitors of viral replication |
| 04/24/2012 | US8163692 Protection against and treatment of ionizing radiation |
| 04/24/2012 | US8163691 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 04/24/2012 | US8163557 Chimaeric human papillomavirus 16 L1 virus-like particles and a method for preparing the particles |
| 04/24/2012 | US8163547 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/24/2012 | US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins |
| 04/24/2012 | US8163521 Self-assembled proteins and related methods and protein structures |
| 04/24/2012 | US8163520 Nucleic acids encoding a chimeric polypeptide comprising IL-7 and HGF-beta chain and methods of use |
| 04/24/2012 | US8163519 Fungal immunomodulatory protein (FIP) prepared by microorganisms and uses thereof |
| 04/24/2012 | US8163503 Methods of identifying compounds that bind TANGO509 |
| 04/24/2012 | US8163494 Method for assessing metastatic properties of breast cancer |